In this episode, Mike Burke, AGG Corporate partner and chair of the international practice, is joined by Pär Remnelid and Olivia Sandin, attorneys at Azelius & Partners, a Swedish law firm. Together, they explore Sweden’s economic landscape and the implementation of its Foreign Direct Investment ("FDI") Act, which affects both domestic and foreign investors.

Mike, Pär, and Olivia discuss how the Swedish FDI regime compares to the U.S. Committee on Foreign Investment in the United States ("CFIUS") process, how it influences deal planning and timing, and what investors should know before entering the Swedish market. The conversation also highlights current M&A trends and the challenges of navigating Sweden’s developing FDI review system.

In this episode, Mike Burke, AGG Corporate partner and chair of the International Practice, sits down with Bri Falcon, AGG Litigation & Dispute Resolution and Intellectual Property of counsel. Mike and Bri discuss the territorial nature of trademark rights and the benefits and limitations of the Madrid Protocol, offering practical guidance for businesses expanding internationally. The conversation explores strategies for prioritizing key jurisdictions, conducting clearance analysis, and avoiding common pitfalls such as trademark squatting and “central attack” risks, helping companies protect their brand assets as they grow.

In this episode, Mike Burke, AGG Corporate partner and chair of the International Practice, welcomes back Sean King, president and founder of Align Global Consulting and the podcast’s very first guest. Mike and Sean discuss how companies can strategically manage tariffs and transfer pricing, while also examining the ripple effects across supply chains, intellectual property, and global tax structures. The conversation highlights opportunities amid uncertainty, from reassessing supply chains and customs valuation to evaluating whether the U.S. itself is becoming a “tax haven.”

In this episode, Mike Burke, AGG Corporate & Finance partner and chair of the firm’s International practice, welcomes lawyer and author Amy Sommers for an insightful discussion on the shifting landscape of U.S.-China relations. Drawing on her 40 years of engagement with China — including more than a decade advising multinational companies in Shanghai — Amy reflects on lessons from history, parallels to the autumn of 1950, and the challenges and opportunities global businesses face amid today’s economic and geopolitical uncertainties.

Mike and Amy discuss the impacts of tariffs, supply chain disruptions, demographic shifts, and regulatory unpredictability, as well as the evolving role of states and CEOs in shaping international investment. They also consider what U.S. companies can learn from navigating China’s complex business environment and how those lessons apply to today’s increasingly fragmented global economy.

In this episode, Mike Burke, AGG Corporate & Finance partner and co-chair of the firm’s International practice, is joined by Allison Raley, AGG partner and member of the International practice, to explore the U.S. tariff changes slated for July 9, 2025.

Mike and Allison analyze the legal and strategic considerations international companies must weigh, including the potential impact of new tariffs under Section 232 investigations. From contract renegotiation and supply chain review to long-term manufacturing decisions, this episode offers timely guidance to help companies proactively mitigate risk.

In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by David Blank, AGG Healthcare partner, to discuss how foreign life sciences companies can proactively address healthcare compliance challenges when expanding into the U.S. market.

Mike and David cover key fraud and abuse laws, including the False Claims Act, the Anti-Kickback Statute, Physician Self-Referral Law (Stark law), and the Civil Monetary Penalties Law, and highlight common mistakes companies make and the severe penalties for non-compliance. As regulatory issues can be incredibly costly and disruptive to a business, Mike and David emphasize the importance of establishing a strong compliance culture from the start.

In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by Andrew Tsui, AGG Healthcare Litigation partner, to explore the intricacies of reimbursement in the U.S. healthcare system. Mike and Andrew discuss challenges foreign life sciences companies face related to Medicare and Medicaid reimbursement, the regulatory hurdles involved, and common pitfalls to avoid. They also highlight the importance of understanding compliance requirements, enforcement mechanisms, and the role of federal agencies in shaping payment determinations.

AGG Corporate partner and co-chair of the firm’s International practice, Mike Burke, is joined by Gabe Scannapieco, AGG Litigation & Dispute Resolution partner, to discuss enforcement trends affecting foreign pharmaceutical and medical device manufacturers. Mike and Gabe explore the increasing regulatory scrutiny on overseas facilities, the role of U.S. agencies in compliance and inspections, and practical steps companies can take to mitigate legal and operational risks when entering the U.S. market.